← All Bills
SB284: Enacting the defense of drug delivery act to prohibit manufacturer interference relating to 340B drug distribution.
In CommitteeSenate
Introduced
In Committee
Passed Chamber
Passed Both
Signed
Plain-Language Summary
This bill aims to protect hospitals and clinics that participate in a program called 340B from drug manufacturers interfering with their ability to distribute discounted drugs to low-income patients.
Who This Affects
This affects Kansas hospitals and clinics that participate in the 340B program, which means they can provide lower-cost medications to vulnerable populations such as Medicaid recipients and uninsured individuals.
Key Provisions
• Prohibits drug manufacturers from interfering with 340B drug distribution
• Protects participating hospitals and clinics from manufacturer interference
• Aims to ensure low-income patients have access to discounted medications
AI-generated summary · verify with full bill text
Timeline
Introduced
Sunday, March 2, 2025
Last Action
House Withdrawn from Committee on Interstate Cooperation; Rereferred to Committee on Health and Human Services
Mar 16, 2026
Sponsors
No sponsors listed.
Track This Bill
Get email alerts when this bill has new action.
Advertisement